This would indicate a 6% year-over-year growth in earnings and a 3% increase in sales when compared to the previous year’s ...

Pfizer ( PFE) reported a beat in second quarter earnings Tuesday, and reaffirmed its 2025 guidance of between $61 to $64 ...

Q3 2025 Management View Stephen D. Westhoven, President and CEO, indicated, "Fiscal 2025 continues to be an excellent year ...

Public Service Enterprise Group delivered strong Q2 results and reaffirmed its 2025 earnings forecast as it ramps up grid ...

Q2 2025 Management View Dave Cramer, President and CEO, reported sequential improvement in occupancy and contract rates, but ...

Over the last five years, the stock has decreased in 56% of these instances, with a median decline of -3.1% and a maximum ...

Advanced Micro Devices, Inc. sees strong Q2 revenue growth led by gaming, but margin compression impacts profits. Click for ...

U.S. commercial revenue skyrocketed 93% year over year on phenomenal demand for the company's artificial intelligence ...

Earnings per share is one of the best metrics of a company’s financial health. In this guide, Benzinga discusses the ins and outs of earnings per share (EPS).

The company assessed goodwill for impairment and recorded a $77 million noncash impairment charge in the pain management and ...

Despite the broader weakness, 18 Nifty50 companies, or 36 per cent, received upward revisions to their FY26 EPS ...

Nifty 50 EPS projected to grow by 10% in FY26, supported by fiscal measures and sectoral preferences, per Motilal Oswal.